# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001144204-13-030407
Filing Date
2013-05-20
Accepted
2013-05-20 13:03:08
Documents
23
Period of Report
2013-05-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | v345690_8k.htm | 8-K | 20933
2 | EX-99.1 | v345690_ex99-1.htm | EX-99.1 | 32054
3 | GRAPHIC | ex99x1_001.jpg | GRAPHIC | 40749
4 | GRAPHIC | ex99x1_002.jpg | GRAPHIC | 105503
5 | GRAPHIC | ex99x1_003.jpg | GRAPHIC | 55704
6 | GRAPHIC | ex99x1_004.jpg | GRAPHIC | 54292
7 | GRAPHIC | ex99x1_005.jpg | GRAPHIC | 61770
8 | GRAPHIC | ex99x1_006.jpg | GRAPHIC | 48161
9 | GRAPHIC | ex99x1_007.jpg | GRAPHIC | 59540
10 | GRAPHIC | ex99x1_008.jpg | GRAPHIC | 65695
11 | GRAPHIC | ex99x1_009.jpg | GRAPHIC | 44553
12 | GRAPHIC | ex99x1_010.jpg | GRAPHIC | 48838
13 | GRAPHIC | ex99x1_011.jpg | GRAPHIC | 73233
14 | GRAPHIC | ex99x1_012.jpg | GRAPHIC | 79520
15 | GRAPHIC | ex99x1_013.jpg | GRAPHIC | 58396
16 | GRAPHIC | ex99x1_014.jpg | GRAPHIC | 61102
17 | GRAPHIC | ex99x1_015.jpg | GRAPHIC | 60066
18 | GRAPHIC | ex99x1_016.jpg | GRAPHIC | 46366
19 | GRAPHIC | ex99x1_017.jpg | GRAPHIC | 50183
20 | GRAPHIC | ex99x1_018.jpg | GRAPHIC | 46187
21 | GRAPHIC | ex99x1_019.jpg | GRAPHIC | 40075
22 | GRAPHIC | ex99x1_020.jpg | GRAPHIC | 64098
23 | GRAPHIC | ex99x1_021.jpg | GRAPHIC | 64885
| Complete submission text file | 0001144204-13-030407.txt |  | 1750615

Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 13857582
SIC: 2834 Pharmaceutical Preparations